These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 21889928)
21. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Shen P; Jiang T; Lu H; Han H; Luo R Cell Biol Int; 2011 Aug; 35(8):803-10. PubMed ID: 21418039 [TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311 [TBL] [Abstract][Full Text] [Related]
23. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells. Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421 [TBL] [Abstract][Full Text] [Related]
24. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917 [TBL] [Abstract][Full Text] [Related]
25. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Wang W; Adachi M; Zhang R; Zhou J; Zhu D Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982 [TBL] [Abstract][Full Text] [Related]
26. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Zhou J; Ye J; Zhao X; Li A; Zhou J Toxicol Appl Pharmacol; 2008 Jul; 230(1):33-40. PubMed ID: 18387645 [TBL] [Abstract][Full Text] [Related]
27. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells. Chen KC; Liu WH; Chang LS J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299 [TBL] [Abstract][Full Text] [Related]
28. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells. Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656 [TBL] [Abstract][Full Text] [Related]
29. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
30. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116 [TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process. Yu C; Rahmani M; Almenara J; Sausville EA; Dent P; Grant S Oncogene; 2004 Feb; 23(7):1364-76. PubMed ID: 14647418 [TBL] [Abstract][Full Text] [Related]
32. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Paul MK; Kumar R; Mukhopadhyay AK Toxicol Appl Pharmacol; 2008 Jan; 226(2):140-52. PubMed ID: 18022205 [TBL] [Abstract][Full Text] [Related]
33. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis. Yan W; Arai A; Aoki M; Ichijo H; Miura O Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Lin TH; Lu FJ; Yin YF; Tseng TH Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345 [TBL] [Abstract][Full Text] [Related]
35. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681 [TBL] [Abstract][Full Text] [Related]
36. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Cao XH; Wang AH; Wang CL; Mao DZ; Lu MF; Cui YQ; Jiao RZ Chem Biol Interact; 2010 Feb; 183(3):357-62. PubMed ID: 19954742 [TBL] [Abstract][Full Text] [Related]
37. Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation. Calviño E; Estañ MC; Sánchez-Martín C; Brea R; de Blas E; Boyano-Adánez Mdel C; Rial E; Aller P J Pharmacol Exp Ther; 2014 Feb; 348(2):324-35. PubMed ID: 24307199 [TBL] [Abstract][Full Text] [Related]
38. Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation. Hong Z; Xiao M; Yang Y; Han Z; Cao Y; Li C; Wu Y; Gong Q; Zhou X; Xu D; Meng L; Ma D; Zhou J Carcinogenesis; 2011 Oct; 32(10):1550-8. PubMed ID: 21803735 [TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Han YH; Kim SZ; Kim SH; Park WH Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383 [TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways. Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]